Nestlé Ponders Least Painful Exit From Peanut Allergy Misfire
Takes $2.1bn Impairment
Heralded as a potential blockbuster, Nestlé's acquisition of Palforzia has proved to be a very expensive mistake.
Heralded as a potential blockbuster, Nestlé's acquisition of Palforzia has proved to be a very expensive mistake.